Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
teer decrease » mean decrease (Expand Search)
Showing 201 - 220 results of 21,342 for search '(( significance ((teer decrease) OR (greater decrease)) ) OR ( significant decrease decrease ))', query time: 0.51s Refine Results
  1. 201
    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function.

    Schematic summary of the proposed role of Epac1 in the regulation of myofilament function. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  2. 202
    Functional characterization of skinned myocardium prepared from Epac1TG.

    Functional characterization of skinned myocardium prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  3. 203
    Epac activation increased RLC phosphorylation via PLC/PKC.

    Epac activation increased RLC phosphorylation via PLC/PKC. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 204
    Phosphorylation status of myofilament proteins prepared from Epac1TG.

    Phosphorylation status of myofilament proteins prepared from Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 205
    Effects of chronic ISO infusion on cardiac function in Epac1TG.

    Effects of chronic ISO infusion on cardiac function in Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 206
    Epac1 expression in the hearts of NTG and Epac1TG.

    Epac1 expression in the hearts of NTG and Epac1TG. by Yoshiki Ohnuki (576298)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 207
    Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesia.

    Effects of pre-medication and warming device on systolic (SAP), diastolic (DAP) and mean (MAP) arterial pressures in dogs following pre-medication, induction and inhalant anesthesi... by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 208
    Change in rectal temperature following pre-medication, induction and inhalant anesthesia.

    Change in rectal temperature following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 209
    Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia.

    Effects of pre-medication and warming device on heart rate (HR) assessed by pulse oximetry in dogs following pre-medication, induction and inhalant anesthesia. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 210
    S1 File -

    S1 File - by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 211
    Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group.

    Times to tracheal extubation, sternal recumbency and standing (minutes) following inhalant anesthesia and final rectal temperatures (°C) in each premedication-treatment group. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  12. 212
    AVAcore placement.

    AVAcore placement. by Jacob P. Rastas (20642173)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  13. 213
    Change in Watt’s Connectedness Scale, Subscales by Treatment Group.

    Change in Watt’s Connectedness Scale, Subscales by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  14. 214
    Primary and secondary efficacy end points (intention-to-treat population).

    Primary and secondary efficacy end points (intention-to-treat population). by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  15. 215
    Demographic and clinical characteristics of participants at baseline.

    Demographic and clinical characteristics of participants at baseline. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  16. 216
    Study-related adverse events.

    Study-related adverse events. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  17. 217
    Study flow chart.

    Study flow chart. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  18. 218
    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group.

    Change in QIDS-SR-16 and MBI-HSS-MP by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  19. 219
    Study CONSORT diagram.

    Study CONSORT diagram. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  20. 220
    Change in Demoralization Scale (DSII) by Treatment Group.

    Change in Demoralization Scale (DSII) by Treatment Group. by Benjamin R. Lewis (22279166)

    Published 2025
    Subjects:
    Save to List
    Saved in:

Search Tools: